Envelope small membrane protein (E protein) (E protein)

The Envelope small membrane protein (E protein) is a small, hydrophobic integral membrane protein found in the viral envelope of coronaviruses, including SARS-CoV-2, SARS-CoV, and MERS-CoV [UniProt: P0DTC4]. It functions primarily as a viroporin, forming cation-selective ion channels that facilitate viral assembly, budding, and the release of progeny virions from the host cell [PubMed: 32835154]. Beyond its structural role, the E protein is a critical virulence factor that modulates the host immune response by activating the NLRP3 inflammasome, which triggers the release of pro-inflammatory cytokines such as IL-1β and IL-18 [PubMed: 31034928]. This inflammatory activity is a major contributor to the lung injury and systemic inflammation observed in severe viral infections. As a therapeutic target, the E protein's ion channel activity can be inhibited by small molecules like hexamethylene amiloride (HMA) and amantadine, which have demonstrated the ability to reduce viral replication and inflammatory signaling in experimental models [PubMed: 33513419]. However, the high mutation rate of viral proteins and the potential for off-target effects on host ion channels present significant challenges for drug development. Additionally, the protein's high hydrophobicity and small size make it a difficult target for traditional high-throughput screening methods. Despite these challenges, targeting the E protein remains a viable strategy for developing broad-spectrum antivirals against emerging coronaviruses.

Other names

E proteinsM proteinSmall envelope proteinViroporin E

Inhibition of viroporin ion channel activity to disrupt viral replication and suppress host inflammatory responses.